Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Others

SELLAS Life Sciences (SLS) Amortization of Deferred Charges (2021)

SELLAS Life Sciences (SLS) has disclosed Amortization of Deferred Charges for 1 consecutive years, with $800000.0 as the latest value for Q1 2021.

Quarterly Amortization of Deferred Charges changed N/A to $800000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $800000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $300000.0 for FY2020, N/A changed from the prior year.
Amortization of Deferred Charges for Q1 2021 was $800000.0 at SELLAS Life Sciences.
The five-year high for Amortization of Deferred Charges was $800000.0 in Q1 2021, with the low at $800000.0 in Q1 2021.